Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
UBS
Mallinckrodt
Accenture
Healthtrust
AstraZeneca
Daiichi Sankyo
Cerilliant
Cantor Fitzgerald

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021016

« Back to Dashboard

NDA 021016 describes RELPAX, which is a drug marketed by Pfizer Ireland and is included in one NDA. It is available from three suppliers. Additional details are available on the RELPAX profile page.

The generic ingredient in RELPAX is eletriptan hydrobromide. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the eletriptan hydrobromide profile page.
Summary for 021016
Tradename:RELPAX
Applicant:Pfizer Ireland
Ingredient:eletriptan hydrobromide
Patents:0
Pharmacology for NDA: 021016
Suppliers and Packaging for NDA: 021016
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RELPAX eletriptan hydrobromide TABLET;ORAL 021016 NDA Roerig 0049-2330 N 0049-2330-45
RELPAX eletriptan hydrobromide TABLET;ORAL 021016 NDA Roerig 0049-2340 N 0049-2340-45

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Dec 26, 2002TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 40MG BASE
Approval Date:Dec 26, 2002TE:ABRLD:Yes

Expired US Patents for NDA 021016

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-002 Dec 26, 2002 ➤ Sign Up ➤ Sign Up
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-002 Dec 26, 2002 ➤ Sign Up ➤ Sign Up
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-001 Dec 26, 2002 ➤ Sign Up ➤ Sign Up
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-001 Dec 26, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Federal Trade Commission
Baxter
Cantor Fitzgerald
US Army
Merck
Healthtrust
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.